Skip to content
Published: 13.02.2025
Jeff Soulliere Director of Strategic Partnerships & Initiatives
KeraLink International
Jeff
1/1

Around the world, more than 12 million people have irreparable damage to the cornea (OR need a cornea transplant), the eye’s clear outer layer.1 Corneal blindness is one of the top five causes of blindness globally, accounting for approximately 3.5% of all cases.2 Despite remarkable advances in eye care that make corneal transplants highly effective—often with success rates of 80–90% or more in well-resourced settings for less acute diseases—access to high-quality donor tissue and adequately equipped medical facilities remains a significant challenge in many low-resource areas.3 Alarmingly, only 1 in 70 people worldwide who need a corneal transplant will receive one.4 Furthermore, in LMICs where infectious keratitis is more prevalent, up to half of patients who receive a corneal transplant will not receive functional vision back.5,6. 

This is where KeraLink International (KLI) steps in. As a nonprofit organization, KLI is dedicated to reducing avoidable blindness by building local capacity and creating sustainable solutions for corneal care. From a tech standpoint, KeraLink is working on projects poised to be game changers in the industry, shaping how corneal blindness is prevented, detected, and treated now and in the future. 

Who We Are 

KLI works to prevent, detect, and treat corneal disease and blindness by providing innovative and affordablesolutions and technologiesto underserved populations inlower-and middle-income communities.KLI unites clinicians, technology innovators, social entrepreneurs, and donors in a coordinated and collaborative effort to address this treatable disease, envisioning aworld where all can see a brighter future. 

Our Legacy and Evolution 

KeraLink International (KLI) traces its roots back more than six decades, when it began as part of what would become the largest network of eye banks in the world. From pioneering cutting-edge technologies to forging strategic alliances with global thought leaders, KLI has evolved from the world’s largest eye banking network into an innovative force for corneal care, dedicated to ensuring that every individual—regardless of location—has the opportunity to receive sight-saving treatment. 

Why We Care About Corneal Blindness 

Corneal blindness, while often overshadowed by other global health challenges, has a profound impact on individuals, families, and communities. When sight is compromised, opportunities for education and employment may be lost, leading to isolation and stigma. According to the World Health Organization (WHO), vision impairment—including corneal blindness—costs the global economy an estimated $411 billion annually in lost productivity.7 

A single corneal transplant can fully restore a person’s sight, independence, and dignity. Yet in many parts of the world, there is a severe shortage of donated corneas, trained professionals, and adequately equipped medical facilities. This shortage is particularly acute in low- and middle-income countries. 

What Makes Us Unique: Capacity Building and Sustainability 

One of the key principles that sets KLI apart is its emphasis on capacity building rather than offering temporary solutions. By partnering with local hospitals, technicians, and healthcare organizations, the organization provides the knowledge and skills necessary to establish world-class eye care practices.
KLI’s approach includes: 

  • Training and Mentorship: Comprehensive training programs for surgeons, nurses, technicians, and remote workers ensure that each region has skilled professionals capable of managing all aspects of corneal care, from tissue recovery and preservation to surgical transplant techniques. 
  • Infrastructure and Equipment: We support local institutions in upgrading their facilities, securing essential equipment, and implementing quality control measures to ensure the availability of safe, high-quality donor tissue. 
  • Sustainable Funding Models: By working with partners to develop financial models, we reduce dependency on external assistance and enable self-sustaining eye care services. 
  • KeraX Venture Lab (launched in January 2025) has embraced a venture studio model—one that transforms bold ideas into viable businesses. Building on the success of Pantheon Vision, KeraLink’s first spinout, KeraX Venture Lab leverages technology, equitable innovation, and entrepreneurship to drive social good. Every new, disruptive technology developed in this space directly supports KLI’s mission of preventing and treating corneal blindness worldwide. 
  • KeraLink Eyewear, the second spinout startup from KeraX Venture Lab, is a groundbreaking online eyewear store launching later this quarter. It stands out from traditional retail eyewear by directing 100% of its profits back into the nonprofit’s mission, funding novel solutions to prevent, detect, and treat corneal disease. 

As part of its recent growth efforts, KLI has appointed Jeff Soulliere as its Director of Strategic Partnerships & Initiatives. With ten years of nonprofit and optical experience, Soulliere has made a name for himself in the industry, winning the IAPB Health Hero Award in Innovation in 2020. His expertise and reputation as a disruptor will be instrumental in driving forward KLI’s mission. It is critical additions like this, along with cutting-edge technology and forward-thinking that make KLI the ideal IAPB partner to help build out IAPB’s corneal blindness arm. 

Looking Ahead 

As an active member of the global eye health community, KLI is proud to collaborate with the IAPB and other partners committed to ending avoidable blindness. KLI will continue serving IAPB’s expansive network of optical-focused partners, championing innovative and affordable solutions to prevent, detect, and treat corneal disease and blindness in underserved populations. across low- and middle-income communities. 

KLI will play an instrumental role in multiple IAPB initiatives in 2025 including: 

  • Refreshing the website with information on corneal blindness 
  • Building out IAPB’s Knowledge Hub 
  • Establishing a unique coalition of world-renowned corneal specialists to help push for advocacy 
  • Creating opportunities for growth 
  • Innovating technology that the IAPB and its partners can benefit from 

Together, let’s create a world where every person has access to the sight-saving care they deserve. 

Join us as we work toward a future free from the limitations of corneal blindness. To learn more about KLI projects, partners, and how to get involved visit www.KeraLink.org and follow them on LinkedIn and Facebook. 

Footnotes  

  1. Gain P, Jullienne R, et al. Global Survey of Corneal Transplantation and Eye Banking. JAMA Ophthalmol. 2016;134(2):167–173. doi:10.1001/jamaophthalmol.2015.4776 
  2. Flaxman SR, Bourne RRA, et al. Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis. Lancet Global Health 2017; 5(12): E1221-E1234. http://dx.doi.org/10.1016/ S2214-109X(17)30393-5 
  3. Terry MA, Aldave A.J, et al. Donor, Recipient, and Operative Factors Associated with Graft Success in the Cornea Preservation Time Study, Ophthalmology, 2018; 125 (11): 1700-1709. https://doi.org/10.1016/j.ophtha.2018.08.002. 
  4. Gain P, Jullienne R, et al. Global Survey of Corneal Transplantation and Eye Banking. JAMA Ophthalmol. 2016;134(2):167–173. doi:10.1001/jamaophthalmol.2015.4776 
  5. Yilmaz YC, Hayat SC, et. al. Tectonic and Therapeutic Urgent Penetrating Keratoplasty Outcomes. Beyoglu Eye J. 2024 Jun 1;9(2):61-68. doi: 10.14744/bej.2024.69772. 
  6. Sharma, Namrata MD; Jain, Mohit MD; et. al. Outcomes of Therapeutic Penetrating Keratoplasty From a Tertiary Eye Care Centre in Northern India. Cornea 33(2):p 114-118, February 2014. | DOI: 10.1097/ICO.0000000000000025 
  7. WHO. Blindness and Vision Impairment. 10 Aug 2023. https://www.who.int/news-room/fact-sheets/detail/blindness-and-visual-impairment